“Potential Benefits of Anticoagulant Doses of Low Molecular Weight Heparin in COVID-19: An Observational Retrospective Study”. Emergency Care Journal, vol. 17, no. 3, Sept. 2021, https://doi.org/10.4081/ecj.2021.9795.